Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants
September 9, 2019 -- Pfizer Inc. (NYSE: PFE) announced today positive preliminary results following administration of three doses in a four-dose series for a Proof-of-Concept Phase 2 study (B7471003) to assess safety and immunogenicity of its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 9, 2019 Category: Pharmaceuticals Source Type: clinical trials

Chronic Otitis Media With Effusion in Chronic Sinusitis With Polyps
Condition:   Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Intervention:   Other: Sinonasal and otologic evaluation Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2019 Category: Research Source Type: clinical trials